Flurbiprofen
- Level
- Commodity
- Parent
- 51384500
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51384508This classification denotes a cyclooxygenase inhibitor and carbonic anhydrase inhibitor with the molecular formula C15H13FO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5GRO578KLP, chemically known as 4-biphenylacetic acid, 2-fluoro-alpha-methyl- but generally known as flurbiprofen, which bears US NIH Compound Identifier 3394. European Medicines Agency schedules Flurbiprofen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07745MIG. The term FLURBIPROFEN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 27, No. 10 1973, List 13). World Health Organization schedules flurbiprofen in its Anatomical Therapeutic Chemical (ATC) Classification. FLURBIPROFEN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule flurbiprofen under HS 29163900 and SITC 51379. As of Q4 2014, FLURBIPROFEN remains the US FDA Preferred Term for this commodity. Flurbiprofen bears US NLM identifiers UMLS ID C0016377 and NCI Concept Code C508. SMILES: FC1C(CCC(C(C)C(=O)O)C1)C1CCCCC1.
Same parent
Under 51384500 · 34Activities that produce or sell this
KBLI · 9Inherited from family 51380000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.